Continuous Quality Improvement - NAPLEX

1. A grocery store pharmacy has a workflow bottleneck: average time from drop-off to verification increased from 18 minutes to 33 minutes over 6 weeks, and the queue peaks between 5–7 PM. Data show pharmacists spend significant time answering phone calls about refill status, and technicians report unclear prioritization between data entry and production. Barriers include limited phone system features and a single pharmacist on duty. The pharmacist-in-charge, staff pharmacist, lead technician, and cashier are involved in CQI. Which CQI tool would best address the identified issue?
   Answer: A time-and-motion study to quantify where delays occur and test workflow changes during peak hours This question tests efficiency analysis tools in Continuous Quality Improvement (CQI) for workflows in a grocery store pharmacy. The bottleneck is prolonged drop-off to verification times from phone interruptions. A time-and-motion study (choice A) quantifies delays for peak-hour optimizations. Opioid evaluations (choice B) are unrelated, stopping phones (choice C) harms service, events (choice D) address morale not process. These miss data collection. Pearl: Time studies identify waste in operational CQI. Apply to bottleneck scenarios with multitasking demands.
2. A community pharmacy launches a new counseling protocol for opioids and notes that documented counseling increased from 40% to 78% over 2 months. However, patient satisfaction related to "time at pickup" decreased from 4.2 to 3.6 out of 5, and average wait time increased by 6 minutes. Barriers include limited staffing and a single pickup window. The pharmacist, technicians, and cashier are involved in CQI to balance safety and experience. What is the most important metric to track for measuring improvement?
   Answer: Rate of documented opioid counseling for new opioid starts and high-risk patients, alongside average wait time at pickup This question assesses balancing metrics in Continuous Quality Improvement (CQI) for opioid counseling in a community pharmacy. The issue is improved documentation but declining satisfaction from longer waits. Tracking counseling rates with wait times (choice A) measures balanced improvements. Total prescriptions (choice B), calls (choice C), and front-end sales (choice D) ignore safety-efficiency trade-offs. These are incomplete. Pearl: Balance quality and efficiency metrics in patient-facing CQI. Framework: Monitor paired indicators to optimize protocols without compromising experience.
3. An ambulatory clinic pharmacy audits diabetes care and finds only 62% of patients prescribed a statin have documentation of guideline-based statin intensity selection, with wide variation among providers. The audit also shows pharmacists are not consistently documenting recommendations in the same location, making follow-up difficult. Barriers include limited time for provider education and inconsistent electronic record templates. The clinical pharmacist, supervising physician, nurse, and informatics analyst are involved in CQI. Which role should the pharmacist take in implementing this CQI initiative?
   Answer: Develop and deliver brief guideline training, standardize documentation templates, and track adherence rates over time This question evaluates pharmacist roles in Continuous Quality Improvement (CQI) for guideline adherence in diabetes care. The issue is low documentation of statin intensity with provider variation. Developing training and templates (choice A) positions the pharmacist to lead education and standardization for better tracking. Nurse-independent changes (choice B) violate protocols, cost focus (choice C) ignores guidelines, and discontinuing audits (choice D) abandons improvement. These undermine collaborative efforts. Pearl: Pharmacists drive evidence-based CQI through education and tools. Framework: Use audits to inform targeted training in multidisciplinary guideline implementation.
4. In a high-volume community pharmacy filling ~450 prescriptions/day, internal incident reports show a dispensing error rate of 2.1 per 1,000 prescriptions over the past 8 weeks, with most errors occurring during the 4–7 pm shift and commonly involving look-alike/sound-alike medications (wrong strength or wrong drug selected). The pharmacy manager notes frequent interruptions at the verification station and inconsistent use of barcode scanning; a potential barrier is staff resistance due to perceived slower workflow. The pharmacist-in-charge, staff pharmacists, pharmacy technicians, and a cashier are available to participate in Continuous Quality Improvement (CQI). How can the pharmacy team best implement changes to reduce dispensing errors in this scenario?
   Answer: Implement a standardized workflow that includes mandatory barcode scanning at product selection and at final verification, and use a brief Plan-Do-Study-Act cycle to test the change during the 4–7 pm shift This question tests the application of Plan-Do-Study-Act (PDSA) cycles to address medication safety through systematic workflow improvement. The pharmacy has identified a specific problem: dispensing errors occurring primarily during peak hours (4-7 pm) involving look-alike/sound-alike medications, with contributing factors of interruptions and inconsistent barcode scanning. Option B is the BEST choice because it addresses the root causes through standardized workflow implementation (mandatory barcode scanning at two critical points) and uses a PDSA cycle to test the change during the problematic time period, allowing for rapid evaluation and adjustment. Option A is incorrect because it inappropriately delegates final verification to non-pharmacist staff, violating legal requirements and potentially increasing errors. Option C fails to change the actual verification process or measure outcomes, making it impossible to determine if the intervention works. Option D is unrealistic given budget constraints and represents an expensive solution without first trying process improvements. The clinical pearl is that effective CQI in pharmacy requires targeting specific root causes with measurable interventions and using rapid-cycle testing (PDSA) to refine solutions before full implementation.
5. A hospital pharmacy is implementing a CQI initiative after discovering that only 68% of medication histories for admitted patients are completed within 24 hours (goal 85%). Data show lower completion rates on Mondays and after holiday weekends, and technicians report they are not always notified when patients arrive on the unit. Barriers include inconsistent admission notifications and limited technician coverage. The transitions-of-care pharmacist, medication history technician, nurse, and unit clerk are involved in CQI. What barrier is most likely to challenge the implementation of this plan?
   Answer: Inconsistent notification to the medication history team when new admissions arrive This question probes barriers in Continuous Quality Improvement (CQI) for medication histories in a hospital. The metric is low timely completions, worse on Mondays. Inconsistent notifications (choice A) challenge implementation by delaying starts. Excess stock (choice B) and no definition (choice C) are not issues, patient lists (choice D) overstates impossibility. These misalign with notification gaps. Pearl: Communication barriers disrupt timely CQI processes. Framework: Standardize alerts in admission workflows for coverage-sensitive tasks.
6. A retail pharmacy's CQI review shows that wrong-patient bagging errors occur at a rate of 3 per 10,000 prescriptions, and 80% happen when one cashier is covering both drive-thru and front counter. Patient complaints include receiving another person's receipt stapled to their bag. Barriers include staffing constraints and limited counter space for organizing completed prescriptions. The pharmacist, lead technician, cashier, and store manager are involved in CQI. How can the pharmacy team best implement changes to reduce dispensing errors?
   Answer: Implement a two-identifier check at pickup and separate staging bins for drive-thru vs front counter, then audit bagging errors weekly This question tests error prevention strategies in Continuous Quality Improvement (CQI) for bagging in a retail pharmacy. The issue is wrong-patient errors from cashier overload. Two-identifier checks and separated bins with audits (choice A) enhance accuracy without disrupting flow. Patient verification in line (choice B) increases waits, manager verification (choice C) is unqualified, eliminating receipts (choice D) ignores root causes. These are inefficient or unsafe. Pearl: Multi-step checks reduce human error in dispensing. In CQI, audit implementations to sustain gains in high-volume pickups.
7. A hospital pharmacy notes that 4.5% of medication deliveries to nursing units are late (over 30 minutes past requested time), and the rate is highest for the emergency department. Data suggest delays often occur when multiple urgent requests arrive simultaneously and the courier is unavailable. Barriers include limited courier coverage and competing priorities between scheduled runs and urgent deliveries. The operations pharmacist, technician, courier, and nurse manager are part of a CQI team. Which CQI tool would best address the identified issue?
   Answer: A Pareto chart of late-delivery reasons (e.g., courier unavailable, batching, verification delays) to prioritize interventions This question evaluates categorization tools in Continuous Quality Improvement (CQI) for medication deliveries in a hospital. The concern is late deliveries to the ED from simultaneous requests. A Pareto chart (choice A) prioritizes reasons for focused fixes. Antibiotic evaluations (choice B) are unrelated, reducing documentation (choice C) hides issues, renovation (choice D) is excessive. These lack prioritization. Pearl: Pareto charts target high-impact factors in logistics CQI. Use for resource-limited delays in critical deliveries.
8. A community pharmacy identifies an increase in near-miss events: 38 near misses in the last month compared with a baseline of 12 per month. Most near misses involve incorrect quantity entry for liquid antibiotics, discovered during final verification; technicians report frequent interruptions and unclear expectations for double-checking calculations. A barrier is time pressure during peak hours. The CQI team includes the pharmacist-in-charge, a staff pharmacist, two technicians, and an intern. What barrier is most likely to challenge the implementation of this plan if the pharmacy introduces a mandatory independent double-check for liquid quantity calculations and a "no interruption" zone during data entry?
   Answer: Staff perception that the added double-check and interruption control will slow workflow during peak times, reducing buy-in This question assesses understanding of implementation barriers in CQI initiatives, particularly staff resistance to workflow changes. The pharmacy plans to implement independent double-checks and no-interruption zones to address a spike in near-miss events (38 vs baseline 12) related to liquid antibiotic calculations. Option A correctly identifies the most likely barrier: staff perception that additional safety steps will slow workflow during busy periods, leading to resistance and poor compliance with the new process. Option B is incorrect because the pharmacy can easily track near-miss reports as an outcome measure. Option C is factually wrong as technicians cannot perform final verification, which is a pharmacist-only function. Option D is irrelevant because sterile compounding hoods aren't needed for routine liquid antibiotic dispensing calculations. The clinical pearl is that successful CQI implementation requires anticipating and addressing staff concerns about workflow impact, often through pilot testing during less busy periods and demonstrating that safety improvements don't necessarily reduce efficiency.
9. A community pharmacy starts a CQI project after medication adherence reports show proportion of days covered (PDC) below 80% for 46% of patients taking antihypertensives. Refill history indicates gaps commonly occur after the first fill, and patients cite forgetfulness and difficulty picking up during work hours. Barriers include limited staff time for outreach and inconsistent collection of preferred contact methods. The pharmacist, technician, and cashier will share responsibilities for the intervention. What is the most effective strategy to improve medication adherence in this scenario?
   Answer: Implement synchronized refills with proactive refill reminders and offer mail delivery or curbside pickup for working patients This question assesses adherence improvement strategies in Continuous Quality Improvement (CQI) for antihypertensives in a community pharmacy. The concern is low proportion of days covered due to refill gaps from forgetfulness and access issues. Synchronized refills with reminders and delivery options (choice A) effectively tackles barriers by proactive engagement and convenience. Waiting for requests (choice B) is passive, increasing prices (choice C) deters adherence, and tracking total prescriptions (choice D) misses adherence specifics. These do not address root causes like timing and outreach. Clinically, synchronization programs enhance PDC by reducing patient effort. Framework: Combine behavioral and logistical interventions in CQI for chronic medication adherence challenges.
10. A community pharmacy experiences frequent stockouts of albuterol inhalers and insulin pen needles, resulting in 22 delayed fills per month and a 15% increase in prescription transfers out over 2 months. Inventory reports show orders are placed inconsistently and reorder points are not standardized; the wholesaler delivers daily but the pharmacy often misses cut-off times. Barriers include limited storage space and inconsistent technician training on inventory tasks. The pharmacist-in-charge, inventory technician, staff pharmacist, and cashier are participating in CQI. Which CQI tool would best address the identified issue?
    Answer: A Plan-Do-Study-Act cycle to test standardized reorder points and daily ordering responsibilities This question examines the use of iterative testing tools in Continuous Quality Improvement (CQI) for inventory management in a community pharmacy. The core issue is frequent stockouts of essential items like albuterol inhalers due to inconsistent ordering and missed cut-off times. A Plan-Do-Study-Act cycle (choice A) is ideal as it allows testing standardized reorder points and responsibilities in small cycles to reduce delays and transfers. Limiting root cause analysis to harm events (choice B) ignores preventive opportunities, a counseling script (choice C) addresses use but not availability, and performance reviews (choice D) focus on individuals rather than processes. These distractors do not systematically test workflow changes needed for inventory consistency. Clinically, PDSA cycles facilitate rapid, data-driven adjustments in operational CQI. Use this framework to pilot and refine interventions in scenarios with variable processes like supply chain management.
11. A community pharmacy identifies that 32% of patients starting inhaled corticosteroids have a refill gap greater than 14 days within the first 3 months. Patient interviews reveal concerns about side effects and uncertainty about daily use when symptoms improve. Barriers include limited time for follow-up calls and inconsistent documentation of inhaler teaching. The pharmacist and technicians are planning a CQI intervention. What is the most effective strategy to improve medication adherence in this scenario?
    Answer: Provide structured first-fill counseling with teach-back on daily use and side effects, then schedule a brief follow-up contact within 2 weeks This question assesses adherence strategies in Continuous Quality Improvement (CQI) for inhaled corticosteroids in a community pharmacy. The metric is high refill gaps from side effect concerns. Structured counseling with follow-up (choice A) addresses uncertainties proactively. Switching inhalers (choice B) is inappropriate, inventory focus (choice C) ignores education, return counts (choice D) mismeasure adherence. These bypass patient engagement. Pearl: Teach-back enhances understanding in adherence CQI. Framework: Combine education and follow-up for new-start medications with barriers.
12. In a hospital central pharmacy, turnaround time for first-dose antibiotics from order verification to delivery increased from a median of 38 minutes to 62 minutes over 8 weeks, and nursing escalations increased from 3 to 11 per week. Data show the largest delays occur between verification and compounding during shift change, and technicians report unclear prioritization of stat orders. Barriers include fixed staffing ratios and limited pneumatic tube capacity. The operations pharmacist, IV room supervisor, technicians, and courier are involved in CQI. What barrier is most likely to challenge the implementation of this plan?
    Answer: Limited ability to add staff during shift change due to fixed staffing budgets and schedules This question probes the identification of implementation barriers in Continuous Quality Improvement (CQI) for antibiotic turnaround times in a hospital pharmacy. The main concern is prolonged delays during shift changes due to unclear prioritization and limited resources. Fixed staffing budgets limiting additions during shift changes (choice A) is the most challenging barrier as it directly impacts the ability to address peak delay periods. Lack of prescriber interest (choice B) and patient refusal (choice C) are unrelated to internal pharmacy workflows, while absent data (choice D) contradicts the provided metrics. These options misdirect from staffing constraints central to the issue. A clinical pearl is that resource barriers like staffing must be anticipated in CQI planning for feasibility. In similar scenarios, map barriers to process steps to prioritize mitigable factors in critical timelines.
13. A community pharmacy reports that vaccine documentation into the state immunization registry is completed within 24 hours for only 70% of vaccinations (goal 95%). Review shows delays occur when the pharmacist is busy and technicians are unsure which fields are required for submission. Barriers include limited technician authorization for registry access and inconsistent training. The pharmacist, immunization technician, and pharmacy manager are involved in CQI. Which role should the pharmacist take in implementing this CQI initiative?
    Answer: Ensure a standardized documentation workflow, train staff on required fields, and monitor 24-hour submission compliance weekly This question tests pharmacist roles in Continuous Quality Improvement (CQI) for vaccine documentation in a community pharmacy. The issue is delayed registry submissions from unclear fields. Standardizing workflows and monitoring (choice A) allows the pharmacist to lead training and compliance. Transferring to cashier (choice B) lacks expertise, stopping during busy times (choice C) reduces quality, tracking doses only (choice D) ignores timeliness. These dilute oversight. Pearl: Pharmacists ensure accuracy in regulatory CQI. Framework: Define training and audits for documentation in immunization programs.
14. A hospital pharmacy conducts a monthly audit of medication reconciliation at discharge. Compliance with documenting a complete home medication list and communicating changes to the patient is 72%, below the hospital target of 90%; the most common omission is failing to document discontinued medications. Barriers include variable discharge timing and inconsistent handoffs between pharmacists and nurses. The CQI team includes a transitions-of-care pharmacist, a staff pharmacist, a pharmacy technician who gathers medication histories, and a unit nurse. Which CQI tool would best address the identified issue?
    Answer: Conduct a root cause analysis on a representative sample of incomplete reconciliations to identify system contributors and standardize a discharge checklist This question evaluates the application of root cause analysis to medication reconciliation failures at transitions of care. The hospital has 72% compliance (below 90% target) with the specific gap being failure to document discontinued medications, complicated by variable discharge timing and poor pharmacist-nurse handoffs. Option A is the BEST choice because root cause analysis will systematically identify why discontinued medications aren't being documented and a standardized discharge checklist will ensure consistent completion regardless of timing or staff involved. Option B abandons quality measurement entirely, preventing identification and correction of potentially dangerous medication errors. Option C measures an unrelated metric (prescription volume) that doesn't reflect reconciliation quality or completeness. Option D inappropriately assigns reconciliation documentation solely to technicians without pharmacist oversight, exceeding their scope and eliminating crucial clinical review. The transferable principle is that root cause analysis combined with standardization tools (checklists) effectively addresses process failures at care transitions where multiple disciplines must coordinate.
15. A hospital central pharmacy notes that 1.6% of intravenous medication doses prepared in the last 2 months required rework due to labeling discrepancies (wrong administration time or missing auxiliary label), leading to delays on nursing units. The issue is more common on weekends, when staffing is lean and a float technician is frequently assigned; a barrier is inconsistent training and unclear accountability for label checks. The CQI team includes the supervising pharmacist, a staff pharmacist, a lead technician, and a float technician. Which role should the pharmacist take in implementing this CQI initiative?
    Answer: Develop and enforce a standardized label verification checkpoint, ensure technician training and competency validation, and review weekend discrepancy rates in CQI meetings This question assesses the pharmacist's leadership role in standardizing processes and ensuring competency in sterile compounding quality improvement. The pharmacy has identified a 1.6% rework rate due to labeling discrepancies, worse on weekends with float staff, indicating training and accountability gaps. Option A is the BEST choice because it addresses all root causes: the pharmacist develops standardized verification checkpoints, ensures proper training and competency validation (especially for float staff), and reviews weekend-specific data in CQI meetings to monitor improvement. Option B inappropriately shifts pharmacy responsibilities to nursing staff who aren't trained in pharmacy labeling requirements and creates patient safety risks. Option C incorrectly assigns CQI leadership to a technician when pharmacists must oversee quality initiatives involving medication safety. Option D eliminates important safety information rather than fixing the process, potentially causing medication errors. The transferable principle is that pharmacists must lead CQI initiatives by standardizing processes, ensuring staff competency through training and validation, and using data stratification to identify when problems occur most frequently.
16. In a hospital pharmacy, incident reports show an increase in wrong-rate infusion pump library selections, from 2 events per month to 9 events per month, with most events involving heparin infusions. Review shows multiple pump library profiles are available, and nurses report confusion about which profile to select after recent updates. Barriers include coordination across nursing education and pharmacy informatics, and limited time for in-person training. The medication safety pharmacist, informatics pharmacist, nurse educator, and staff pharmacist are involved in CQI. How can the pharmacy team best implement changes to reduce dispensing errors?
    Answer: Standardize and simplify pump library profiles, communicate updates with targeted training, and track wrong-profile selection events monthly This question examines safety implementations in Continuous Quality Improvement (CQI) for infusion pumps in a hospital. The issue is wrong-profile selections post-updates. Standardizing profiles with training and tracking (choice A) reduces confusion effectively. Disabling libraries (choice B) removes safeguards, technician education (choice C) oversteps roles, cost focus (choice D) ignores safety. These are risky or off-target. Pearl: Simplified tech with education prevents errors in devices. In CQI, collaborate across teams for device-related safety enhancements.
17. A community pharmacy's patient satisfaction surveys (n=120 over 2 months) show counseling-related scores averaging 3.1/5, with frequent comments that counseling is rushed and inconsistent for new medications. Only 42% of new prescriptions have documented counseling offers, and technicians report they are unsure when to alert the pharmacist. Barriers include limited staffing during lunch hours and variable pharmacist counseling styles. The team includes the pharmacist-in-charge, a staff pharmacist, two technicians, and a clerk. Which role should the pharmacist take in implementing this CQI initiative?
    Answer: Lead development of a standardized counseling protocol and train technicians on consistent triggers for pharmacist referral, then monitor documentation rates over time This question assesses the pharmacist's leadership role in standardizing patient care processes within CQI initiatives. The pharmacy has identified poor counseling satisfaction (3.1/5) with specific issues of rushed, inconsistent counseling and unclear technician triggers for pharmacist involvement. Option B is the BEST choice because it positions the pharmacist as a leader who develops standardized protocols, ensures proper training, and establishes clear referral criteria while monitoring outcomes - all essential pharmacist responsibilities in CQI. Option A inappropriately delegates counseling content selection to technicians, exceeding their scope of practice and potentially compromising patient safety. Option C assigns counseling to clerks who lack the training and legal authority to provide medication counseling. Option D abandons a core pharmacy service rather than improving it, which violates professional obligations and likely worsens patient outcomes. The clinical pearl is that pharmacists must lead CQI initiatives involving clinical services by developing standards, training staff appropriately within their scope, and establishing measurable monitoring systems.
18. In a hospital unit-dose setting, barcode scanning compliance prior to administration is 86% (goal 95%), and near-miss reports show multiple instances of look-alike unit-dose packages being selected. Pharmacy data show that 70% of selection errors occur for two similar-sounding medications stored adjacent in the carousel. Barriers include space constraints in the carousel and nursing concerns about added steps. The decentralized pharmacist, pharmacy technician, nurse educator, and medication safety officer are involved in CQI. How can the pharmacy team best implement changes to reduce dispensing errors?
    Answer: Relocate and separate look-alike items, add tall-man lettering and barcode verification at dispensing, and monitor error rates monthly This question examines error reduction implementations in Continuous Quality Improvement (CQI) for unit-dose dispensing in a hospital. The issue is low barcode compliance and look-alike selection errors from adjacent storage. Relocating items with tall-man lettering and barcode verification (choice A) directly mitigates risks through storage and tech enhancements. Stopping near-miss reports (choice B) hides issues, nurse restocking (choice C) shifts burdens, and EHR replacement (choice D) is overly broad. These avoid targeted safety layers. Pearl: Layered safeguards like separation and alerts prevent high-alert errors. In CQI, monitor post-implementation metrics to ensure sustained safety in dispensing.
19. In a hospital outpatient pharmacy, average prescription turnaround time increased from 18 minutes to 32 minutes over 6 weeks, and 25% of patients now wait longer than 45 minutes during weekday afternoons. Observation shows bottlenecks when technicians alternate between data entry and insurance problem-solving, leaving the filling station idle. A barrier is limited cross-training and reluctance to change long-standing task assignments. The team includes a staff pharmacist, two technicians, and a pharmacy intern. Which CQI tool would best address the identified issue?
    Answer: Use a cause-and-effect (fishbone) diagram to categorize potential contributors (people, process, environment, technology) and prioritize a testable workflow change This question tests understanding of root cause analysis tools for workflow optimization in pharmacy operations. The pharmacy has identified increased turnaround times (18 to 32 minutes) with specific bottlenecks when technicians multitask between data entry and insurance issues, leaving filling stations idle. Option A is the BEST choice because a fishbone diagram systematically categorizes all potential contributors (people, process, environment, technology) to identify root causes and prioritize testable solutions for the workflow bottleneck. Option B merely tells staff to work faster without addressing underlying workflow issues, which typically fails and may increase errors. Option C focuses on a single metric (insurance rejections) that doesn't capture the full workflow problem of task-switching and idle stations. Option D jumps to an expensive technology solution without first understanding current workflow problems or ensuring staff readiness. The transferable principle is that systematic root cause analysis using structured tools like fishbone diagrams must precede solution implementation to ensure interventions target actual causes rather than symptoms.
20. A hospital inpatient pharmacy reports that 2.2% of medication orders requiring renal dose adjustment were verified without adjustment in the last quarter (up from 0.9% previously). A chart audit shows most misses occur on weekends when staffing is lean, and the electronic health record displays estimated glomerular filtration rate on a separate tab. Barriers include limited information technology build time and variable prescriber acceptance of pharmacist recommendations. The clinical pharmacist, informatics pharmacist, staff pharmacist, and technicians are involved in CQI. What is the most important metric to track for measuring improvement?
    Answer: Percentage of renal dose-adjustment-eligible orders verified with the correct adjusted dose This question evaluates the selection of performance metrics in Continuous Quality Improvement (CQI) for monitoring renal dose adjustments in a hospital pharmacy. The key metric of concern is the increased percentage of unadjusted renal dose-eligible orders, particularly on weekends with lean staffing. Tracking the percentage of correctly adjusted doses (choice A) is optimal because it directly measures improvement in verification accuracy and can be stratified by variables like staffing levels. The total orders verified per pharmacist (choice B) assesses productivity but not adjustment quality, while formulary noncompliance interventions (choice C) and cart-fill times (choice D) address unrelated aspects like adherence and efficiency. These alternatives overlook the core issue of missed adjustments due to EHR navigation and weekend barriers. Clinically, effective CQI metrics should be specific, measurable, and tied to patient safety outcomes like dose accuracy. Apply this framework by aligning metrics with identified failure points in high-risk processes such as renal dosing.

Start this quiz